Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:3680-3686
Published online before print November 29, 2004, doi: 10.1161/01.CIR.0000149748.79945.52
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/24/3680    most recent
01.CIR.0000149748.79945.52v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlaich, M. P.
Right arrow Articles by Kaye, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlaich, M. P.
Right arrow Articles by Kaye, D. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Hypertension - basic studies

(Circulation. 2004;110:3680-3686.)
© 2004 American Heart Association, Inc.


Hypertension

Impaired L-Arginine Transport and Endothelial Function in Hypertensive and Genetically Predisposed Normotensive Subjects

Markus P. Schlaich, MD; Melinda M. Parnell, PhD; Belinda A. Ahlers, PhD; Samara Finch, BSc; Tanneale Marshall, BSc; Wei-Zheng Zhang, PhD; David M. Kaye, MD, PhD

From the Wynn Department of Metabolic Cardiology, Baker Heart Research Institute, Melbourne, Victoria, Australia.

Correspondence to Dr David Kaye, Wynn Department of Metabolic Cardiology, Baker Heart Research Institute, PO Box 6492, St Kilda Rd Central, Melbourne, Victoria 8008, Australia. E-mail david.kaye{at}baker.edu.au

Received July 5, 2004; accepted August 9, 2004.

Background— Impaired endothelium-dependent NO-mediated vasodilation is a key feature of essential hypertension and may precede the increase in blood pressure. We investigated whether transport of the NO precursor L-arginine is related to decreased endothelial function.

Methods and Results— Radiotracer kinetics ([3H]L-arginine) were used to measure forearm and peripheral blood mononuclear cell arginine uptake in hypertensive subjects (n=12) and in 2 groups of healthy volunteers with (n=15) and without (n=15) a family history of hypertension. In conjunction, forearm blood flow responses to acetylcholine and sodium nitroprusside were measured before and after a supplemental intra-arterial infusion of L-arginine. In vivo and in vitro measures of L-arginine transport were substantially reduced in the essential hypertension and positive family history groups compared with the negative family history group; however, no difference was detected in peripheral blood mononuclear cell mRNA or protein expression levels for the cationic amino acid transporter CAT-1. Plasma concentrations of L-arginine and NG,NG'-dimethylarginine (ADMA) did not differ between groups. L-Arginine supplementation improved the response to acetylcholine only in subjects with essential hypertension and positive family history.

Conclusions— Similar to their hypertensive counterparts, normotensive individuals at high risk for the development of hypertension are characterized by impaired L-arginine transport, which may represent the link between a defective L-arginine/NO pathway and the onset of essential hypertension. The observed transport defect is not due to apparent alterations in CAT-1 expression or elevated endogenous ADMA.


Key Words: hypertension • endothelium • nitric oxide • amino acids • arginine




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. Gkaliagkousi, J. Ritter, and A. Ferro
Platelet-Derived Nitric Oxide Signaling and Regulation
Circ. Res., September 28, 2007; 101(7): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. A. Holowatz and W. L. Kenney
Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans
J. Physiol., June 1, 2007; 581(2): 863 - 872.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Yang, K. Venardos, E. Jones, B. J. Morris, J. Chin-Dusting, and D. M. Kaye
Identification of a Novel Polymorphism in the 3'UTR of the L-Arginine Transporter Gene SLC7A1: Contribution to Hypertension and Endothelial Dysfunction
Circulation, March 13, 2007; 115(10): 1269 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. A. Augustyniak, R. G. Victor, D. A. Morgan, and W. Zhang
L-NAME- and ADMA-induced sympathetic neural activation in conscious rats
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R726 - R732.
[Abstract] [Full Text] [PDF]